Markers proposed to be related to increased disease activity and/or severity. ‡ Markers that have been associated with Behcet's disease. § Innate immunity. AB: Antibody; ACA: Anticardiolipin ...

Behçet disease is a chronic multisystem inflammatory disorder with oral and genital ulcers present in up to 95% of patients. Skin manifestations are often papulopustular rashes or erythema ...

Behçet's disease (BD) is a systemic large-vessel vasculitis characterized by a wide clinical spectrum including recurrent oral and genital ulcerations, uveitis, and vascular, neurological ...

Hi, everyone, and welcome to the next episode of our CEO Fireside Chats. My name is David Bautz and I'm a senior biotechnology analyst here at Zacks Small Cap Research. Joining me today is Chris ...

Chairman and CEO Dr. Christopher Schaber joined IBN's BioMedWire Podcast to discuss the company's two-pronged business ...

Soligenix (NASDAQ: SNGX) , a late-stage biopharmaceutical company, is advancing its phase 3 replication study (“FLASH2”) for HyBryte(TM), a novel pho ...

Chairman and CEO Dr. Christopher Schaber joined IBN’s BioMedWire Podcast to discuss the company’s two-pronged business model, robust late-stage pipeline, and ongoing clinical trials. Schaber ...

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...

Nippon Shinyaku Co. Ltd. has divulged azaindole compounds acting as mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1) inhibitors reported to be useful for the treatment of ...